201741-17-5 Usage
Description
(4-Hydroxy-2-methylphenyl)carbamic acid tert-butyl ester, also known as zolimidine, is a chemical compound with the molecular formula C12H17NO3. It is an ester of (4-hydroxy-2-methylphenyl)carbamic acid and is commonly used as a pesticide and a drug intermediate. Zolimidine is a white crystalline solid with a slight floral odor, and it is soluble in organic solvents. It has been extensively studied for its potential use as an anticonvulsant and antiepileptic drug, as well as for its pesticidal properties. In addition, the tert-butyl ester group provides stability and acts as a protecting group for the carbamic acid, making it useful in organic synthesis and pharmaceutical research.
Uses
Used in Pharmaceutical Industry:
(4-Hydroxy-2-methylphenyl)carbamic acid tert-butyl ester is used as a drug intermediate for the development of anticonvulsant and antiepileptic drugs. Its potential use in treating seizure disorders and epilepsy has been extensively studied.
Used in Pesticide Industry:
(4-Hydroxy-2-methylphenyl)carbamic acid tert-butyl ester is used as a pesticide due to its pesticidal properties. It helps in controlling and managing pests in agricultural settings.
Used in Organic Synthesis:
(4-Hydroxy-2-methylphenyl)carbamic acid tert-butyl ester is used as a protecting group for carbamic acid in organic synthesis. The tert-butyl ester group provides stability, making it useful in various chemical reactions and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 201741-17-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,1,7,4 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 201741-17:
(8*2)+(7*0)+(6*1)+(5*7)+(4*4)+(3*1)+(2*1)+(1*7)=85
85 % 10 = 5
So 201741-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO3/c1-8-7-9(14)5-6-10(8)13-11(15)16-12(2,3)4/h5-7,14H,1-4H3,(H,13,15)
201741-17-5Relevant articles and documents
POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES
-
Page/Page column 132, (2021/01/29)
The current invention provides urea derivatives, in particular compounds having the core structure heteroaryl-NH-CO-NH-aryl-O- heteroaryl, for use in treating, ameliorating, delaying, curing and/ or preventing a disease or condition associated with muscle cells and/or satellite cells, such as Duchenne muscular dystrophy, Becker muscular dystrophy, cachexia or sarcopenia.
Rearrangement of differentially protected N-arylhydroxylamines
Porzelle, Achim,Woodrow, Michael D.,Tomkinson, Nicholas C. O.
experimental part, p. 5135 - 5143 (2009/06/17)
The rearrangement of a series of N,O-difunctionalised N-arylhydroxylamines to generate protected 2-aminophenols has been investigated. N-Boc-N-Aryl-O- acylhydroxylamines are stable, isolable compounds which rearrange smoothly at temperatures between 110 and 140°C. The corresponding N-Boc-N-aryl-O- sulfonylhydroxylamines were not isolated and rearrange to 1,2-difunctionalised aminophenols at room temperature in excellent yield. Deprotection of either the N- or O-substituents under standard conditions allows for further synthetic manipulation of either the aniline or phenol functionality. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.
Fibrinogen receptor antagonist prodrugs
-
, (2008/06/13)
Fibrinogen receptor antagonist alcohol prodrugs having the structure, for example, of more particularly, STR1
